Gisela Walgenbach‐Brünagel

MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels

Lena M. Wulfken, Rudolf Moritz, Carsten‐Henning Ohlmann et al. · PLoS ONE · 2011 · 230 citations · Full text

Medicine, Cancer Biology, Oncology +17

Circulating mitochondrial DNA in serum: A universal diagnostic biomarker for patients with urological malignancies

Jörg Ellinger, David C. Müller, Stefan C. Müller et al. · Urologic Oncology Seminars and Original Investigations · 2010 · 104 citations

Medicine, Oncology, Urology +12

Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma

Stefan Hauser, Lena M. Wulfken, Stefan Holdenrieder et al. · Cancer Epidemiology · 2012 · 101 citations

Medicine, Molecular Medicine, Oncology +16

Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma

Imke Sanders, Stefan Holdenrieder, Gisela Walgenbach‐Brünagel et al. · International Journal of Urology · 2012 · 91 citations

Medicine, Oncology, Urology +15

Clinical Performance of CEA, CA19-9, CA15-3, CA125 and AFP in Gastrointestinal Cancer Using LOCI™-based Assays

Ramona Dolscheid‐Pommerich, Steffen Manekeller, Gisela Walgenbach‐Brünagel et al. · Anticancer Research · 2017 · 45 citations · Full text

Medicine, Oncology, Pathology +17